Hong Deng

4.1k total citations · 1 hit paper
148 papers, 3.0k citations indexed

About

Hong Deng is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Hong Deng has authored 148 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 43 papers in Epidemiology and 35 papers in Hepatology. Recurrent topics in Hong Deng's work include Liver Disease Diagnosis and Treatment (28 papers), Hepatitis C virus research (27 papers) and Hepatitis B Virus Studies (26 papers). Hong Deng is often cited by papers focused on Liver Disease Diagnosis and Treatment (28 papers), Hepatitis C virus research (27 papers) and Hepatitis B Virus Studies (26 papers). Hong Deng collaborates with scholars based in China, United States and Germany. Hong Deng's co-authors include Zhouping Tang, Zhiliang Gao, Qianling Zhang, Liang‐Nian Ji, Zhiyong Guo, Hong Xu, Shicheng Su, Qiyi Zhao, Huixin Liang and Xiaoding Xu and has published in prestigious journals such as Cell, Angewandte Chemie International Edition and Journal of Clinical Investigation.

In The Last Decade

Hong Deng

139 papers receiving 2.9k citations

Hit Papers

Targeting Mitochondria-Located circRNA SCAR Alleviates NA... 2020 2026 2022 2024 2020 100 200 300

Peers

Hong Deng
Xiaoyu Xu China
Ling Dong China
Min Young Kim South Korea
Xiaoyu Xu China
Hong Deng
Citations per year, relative to Hong Deng Hong Deng (= 1×) peers Xiaoyu Xu

Countries citing papers authored by Hong Deng

Since Specialization
Citations

This map shows the geographic impact of Hong Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Deng more than expected).

Fields of papers citing papers by Hong Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Deng. The network helps show where Hong Deng may publish in the future.

Co-authorship network of co-authors of Hong Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Deng. A scholar is included among the top collaborators of Hong Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Deng. Hong Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ye, Junzhao, Jiaming Lai, Xiaodong Zhuang, et al.. (2025). Machine Learning Models for Screening Steatosis in MASLD : An International Validation Study. Liver International. 45(12). e70416–e70416.
4.
Liu, Qing, et al.. (2024). Comprehensive Quality Evaluation of Danggui–Jianzhong Decoction by Fingerprint Analysis, Multi-Component Quantitation and UPLC-Q-TOF-MS. Journal of Chromatographic Science. 62(7). 635–648. 2 indexed citations
7.
Deng, Hong, et al.. (2023). Regulation of Cat8 in energy metabolic balance and glucose tolerance in Saccharomyces cerevisiae. Applied Microbiology and Biotechnology. 107(14). 4605–4619. 3 indexed citations
8.
Ren, Lei, et al.. (2023). Dual-Regulated Mechanism of EZH2 and KDM6A on SALL4 Modulates Tumor Progression via Wnt/β-Catenin Pathway in Gastric Cancer. Digestive Diseases and Sciences. 68(4). 1292–1305. 6 indexed citations
9.
Gao, Na, Guiwen Guan, Ganlin Xu, et al.. (2023). Integrated HBV DNA and cccDNA maintain transcriptional activity in intrahepatic HBsAg‐positive patients with functional cure following PEG‐IFN‐based therapy. Alimentary Pharmacology & Therapeutics. 58(10). 1086–1098. 15 indexed citations
10.
Zhou, Jing, et al.. (2022). MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients. SHILAP Revista de lepidopterología. 8 indexed citations
11.
Bai, Shuang, Wenliang Guo, Yangyang Feng, et al.. (2019). Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials. Journal of Neurology Neurosurgery & Psychiatry. 91(1). 21–32. 151 indexed citations
12.
Liu, Chengcheng, et al.. (2019). Hypocrellin B-Mediated Photodynamic Inactivation of Gram-Positive Antibiotic-Resistant Bacteria: An In Vitro Study. Photobiomodulation Photomedicine and Laser Surgery. 38(1). 36–42. 12 indexed citations
13.
Xu, Wenxiong, Qian Zhang, Xiang Zhu, et al.. (2018). 48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse. Canadian Journal of Gastroenterology and Hepatology. 2018. 1–11. 8 indexed citations
14.
Yuan, Guosheng, Junwei Liu, Huaping Huang, et al.. (2018). Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China. Canadian Journal of Gastroenterology and Hepatology. 2018. 1–8. 17 indexed citations
15.
Li, Xinhua, Jing Huang, Hong Deng, et al.. (2018). IFI16 is involved in HBV-associated acute-on-chronic liver failure inflammation. BMC Gastroenterology. 18(1). 61–61. 15 indexed citations
16.
Zhao, Qiyi, et al.. (2018). Increased CCR7loPD-1hiCXCR5+CD4+ T Cells in Peripheral Blood Mononuclear Cells Are Correlated with Immune Activation in Patients with Chronic HBV Infection. Canadian Journal of Gastroenterology and Hepatology. 2018. 1–9. 7 indexed citations
17.
Kuang, Dong‐Ming, Christos Xiao, Qiyi Zhao, et al.. (2014). B7-H1–expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets. Journal of Clinical Investigation. 124(10). 4657–4667. 68 indexed citations
18.
Yang, Xiaobing, et al.. (2014). [Treating primary liver cancer patients by Pi-strengthening and Qi-regulating method: univariate and multivariate analyses of their prognoses].. PubMed. 34(2). 162–6. 2 indexed citations
19.
Huang, Zhanlian, Hong Deng, Qiyi Zhao, et al.. (2013). Peginterferon-α2a combined with response-guided short-term lamivudine improves response rate in hepatitis B e antigen-positive hepatitis B patients. European Journal of Gastroenterology & Hepatology. 25(10). 1–1. 9 indexed citations
20.
Lu, Ze, Yong Zhou, Shuang Zhang, et al.. (2011). The effect of miR‐7 on behavior and global protein expression in glioma cell lines. Electrophoresis. 32(24). 3612–3620. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026